Cigarette Smoking
214
21
24
160
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
70 trials with published results (33%)
Research Maturity
160 completed trials (75% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
5.1%
11 terminated out of 214 trials
93.6%
+7.1% vs benchmark
7%
16 trials in Phase 3/4
44%
70 of 160 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 160 completed trials
Clinical Trials (214)
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
Testing the ETM: Examination and Comparison of Different Methods
Remote Interventions for Menthol Cigarette Use
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
Beta-Adrenergic Modulation of Drug Cue Reactivity
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
Menthol, Inflammation, and Nicotine Transition Study
RTMS Targets Neural Circuits for Smoking Cessation
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
Mapping Brain Glutamate in Humans: Sex Differences in Cigarette Smokers
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers
STARS (Smoking Treatment And Remote Sampling) Study
Semaglutide for Post-Smoking Cessation Weight Management